Latest filing published 25 Sept 2023 for Decibel Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Anna Trask appears in our data through filings on Decibel Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 October 2021 to 25 September 2023, the count stands at 7 filings.
On the market, this insider has only sold: 5 sales, €100k in total. Besides market trades, the filings include 1 share grant.
Most recently, on 25 September 2023, the filings show a transaction in Decibel Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations